Back

LKB1 suppresses growth and promotes the internalization of EGFR through the PIKFYVE lipid kinase

Ferrarone, J.; Thomas, J.; Unni, A.; Zheng, Y.; Nagiec, M.; Gardner, E.; Mashadova, O.; Li, K.; Koundouros, N.; Montalbano, A.; Mustafa, M.; Cantley, L.; Blenis, J.; Sanjana, N.; Varmus, H.

2023-10-20 cancer biology
10.1101/2023.10.19.563158 bioRxiv
Show abstract

The tumor suppressor LKB1 is a serine/threonine protein kinase that is frequently mutated in human lung adenocarcinoma (LUAD). LKB1 regulates a complex signaling network that is known to control cell polarity and metabolism; however, the pathways that mediate the tumor suppressive activity of LKB1 are incompletely defined. To identify mechanisms of LKB1- mediated growth suppression we developed a spheroid-based cell culture assay to study LKB1- dependent growth. Using this assay, along with genome-wide CRISPR screens and validation with orthogonal methods, we discovered that LKB1 suppresses growth, in part, by activating the PIKFYVE lipid kinase, which promotes the internalization of wild-type EGFR. Our findings reveal a new mechanism of regulation of EGFR, which may have implications for the treatment of LKB1-mutant LUAD.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.